Castelain P, Hendrickx B, Tromelin A, Demerseman P, Moens W
Institute of Hygiene and Epidemiology, Vrije Universiteit van Brussel, Belgium.
Mutat Res. 1992 Jul;280(1):9-15. doi: 10.1016/0165-1218(92)90013-p.
The mutagenic activity of five dichloroethylamino 2-nitrobenzofuran derivatives and one dichloroethylamino 2-nitronaphthofuran derivative was analysed in the Salmonella/microsome assay. We investigated the influence of the position of the dichloroethylamino and/or the methoxy groups on the mutagenic activity of these nitro arenofurans in S. typhimurium strain TA100 and its variant TA100NR, deficient in nitroreductase. Without metabolic activation 7-[bis(2-chloroethyl)amino]-2-nitronaphtho[2,1-b]furan (1), 4-[bis(2-chloroethyl)amino]-7-methoxy-2-nitrobenzofuran (2), 7-[bis(2-chloroethyl)amino]-4-methoxy-2-nitrobenzofuran (5) and 6-[bis(2-chloroethyl)amino]-2-nitrobenzofuran (6) are mutagenic in TA100, while 4-[bis(2-chloroethyl)amino]-5-methoxy-2-nitrobenzofuran (4) is weakly mutagenic and 5-[bis(2-chloroethyl)-amino]-2-nitrobenzofuran (3) toxic. In the NR deficient strain compounds 1, 3 and 6 are strong mutagens and 4 is weakly positive. The two isomers 2 and 5 are negative in that strain. The naphthofuran derivative 1 is highly mutagenic in the absence of S9 mix in both strains considered, but less than R7000 (7). A decrease in the electronic polarity of compound 1 versus compound 7 according to the hypothesis developed by Royer et al. is a possible explanation. After exogenous metabolic activation by S9 mix all the compounds tested are highly mutagenic in both Salmonella strains. The position of the dichloroethylamino group and/or the presence of a methoxyl on the alpha-nitroarenofuran derivatives seem to modify the activity of bacterial as well as exogenous nitroreductases or other activating enzymes.
在沙门氏菌/微粒体试验中分析了五种二氯乙氨基-2-硝基苯并呋喃衍生物和一种二氯乙氨基-2-硝基萘并呋喃衍生物的致突变活性。我们研究了二氯乙氨基和/或甲氧基的位置对这些硝基芳基呋喃在鼠伤寒沙门氏菌TA100菌株及其缺乏硝基还原酶的变体TA100NR中的致突变活性的影响。在没有代谢活化的情况下,7-[双(2-氯乙基)氨基]-2-硝基萘并[2,1-b]呋喃(1)、4-[双(2-氯乙基)氨基]-7-甲氧基-2-硝基苯并呋喃(2)、7-[双(2-氯乙基)氨基]-4-甲氧基-2-硝基苯并呋喃(5)和6-[双(2-氯乙基)氨基]-2-硝基苯并呋喃(6)在TA100中具有致突变性,而4-[双(2-氯乙基)氨基]-5-甲氧基-2-硝基苯并呋喃(4)具有弱致突变性,5-[双(2-氯乙基)氨基]-2-硝基苯并呋喃(3)具有毒性。在缺乏NR的菌株中,化合物1、3和6是强诱变剂,4呈弱阳性。两种异构体2和5在该菌株中呈阴性。萘并呋喃衍生物1在两种受试菌株中,在没有S9混合物的情况下具有高度致突变性,但低于R7000(7)。根据Royer等人提出的假设,化合物1与化合物7相比电子极性的降低是一种可能的解释。经S9混合物进行外源性代谢活化后,所有测试化合物在两种沙门氏菌菌株中均具有高度致突变性。α-硝基芳基呋喃衍生物上二氯乙氨基的位置和/或甲氧基的存在似乎会改变细菌以及外源性硝基还原酶或其他活化酶的活性。